SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-039140
Filing Date
2021-07-29
Accepted
2021-07-29 16:15:55
Documents
15
Period of Report
2021-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR PRIVATE PLACEMENT crnx-8k_20210728.htm   iXBRL 8-K 50101
2 EX-99.1 crnx-ex991_6.htm EX-99.1 189704
3 EX-99.2 crnx-ex992_7.htm EX-99.2 12854
4 GRAPHIC gedd0wskmqi3000001.jpg GRAPHIC 3697
  Complete submission text file 0001564590-21-039140.txt   434044

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210728.xsd EX-101.SCH 5689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210728_lab.xml EX-101.LAB 20069
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210728_pre.xml EX-101.PRE 11937
8 EXTRACTED XBRL INSTANCE DOCUMENT crnx-8k_20210728_htm.xml XML 3691
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 211127610
SIC: 2834 Pharmaceutical Preparations